Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stromelysin/transin and tumor progression.

L M Matrisian1, G T Bowden

  • 1Department of Cell Biology, Vanderbilt University, Nashville, TN 37232.

Seminars in Cancer Biology
|April 1, 1990
PubMed
Summary

Transin, a metalloproteinase, is regulated by oncogenes and growth factors, and its expression links to cancer progression. Its activity is controlled transcriptionally, via precursor processing, and by inhibitors, highlighting its role in tumor development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fyn is a redox sensor involved in solar ultraviolet light-induced signal transduction in skin carcinogenesis.

Oncogene·2015
Same author

Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.

Oncogene·2015
Same author

Stability of sulforaphane for topical formulation.

Drug development and industrial pharmacy·2013
Same author

Effects of acute and chronic arsenic exposure of human-derived keratinocytes in an In Vitro human skin equivalent system: a novel model of human arsenicism.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Ultraviolet B regulation of transcription factor families: roles of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis.

Current cancer drug targets·2007
Same author

Insights from knock-out models concerning postischemic release of TNFalpha from isolated mouse hearts.

Journal of molecular and cellular cardiology·2006

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Transin is an oncogene-inducible protein and the rat homologue of stromelysin.
  • Stromelysin is an extracellular matrix-degrading metalloproteinase.
  • Its expression is associated with tumor progression, suggesting a role in cancer.

Purpose of the Study:

  • To investigate the regulatory mechanisms of transin/stromelysin activity.
  • To understand the role of transin/stromelysin in cancer progression.

Main Methods:

  • Analysis of transcriptional regulation by oncogenes, growth factors, and inhibitors.
  • Investigation of post-translational processing of the inactive precursor form.
  • Assessment of modulation by tissue inhibitors of metalloproteinases (TIMPs).

Main Results:

  • Transin/stromelysin is transcriptionally regulated by oncogenes, tumor promoters, and growth factors.
  • Negative regulation occurs with glucocorticoids and transforming growth factor-beta.
  • Protease activity is controlled by precursor processing and TIMPs.

Conclusions:

  • Transin/stromelysin activity is multi-level regulated.
  • Its association with tumor progression underscores its importance in cancer.

Related Experiment Videos